MAPS plans to seek ap­proval of MD­MA-as­sist­ed ther­a­py this year af­ter sec­ond pos­i­tive PhI­II tri­al

MAPS Pub­lic Ben­e­fit Cor­po­ra­tion is tout­ing an­oth­er set of promis­ing Phase III re­sults in­ves­ti­gat­ing its MD­MA-as­sist­ed ther­a­py for post-trau­mat­ic stress dis­or­der (PTSD), with the tri­al …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER